Sort by
Refine Your Search
-
Category
-
Program
-
Field
-
/ProvinceProvinciaCityBarcelonaPostal Code08003StreetC/ Dr Aiguader 88 Where to apply Website https://recruitment.crg.eu/content/jobs/position/bioinformatics-developer-biodi… Contact State/Province Barcelona City Barcelona Website http
-
The Institute The Centre for Genomic Regulation (CRG) is an international biomedical research institute of excellence, based in Barcelona, Spain, with more than 400 scientists from 44 countries. The CRG is composed by an interdisciplinary, motivated and creative scientific team which is...
-
The Institute The Centre for Genomic Regulation (CRG) is an international biomedical research institute of excellence, based in Barcelona, Spain, with more than 400 scientists from 44 countries. The CRG is composed by an interdisciplinary, motivated and creative scientific team which is...
-
are a leading research group dedicated to implementing generative AI models to revolutionize protein engineering and design. Our multidisciplinary team combines expertise in bioinformatics, machine
-
RNA quality control and NGS library preparation, including 2 TECAN robots for automation of protocols. The Genomics Unit is embedded in the CRG Core Technologies Programme that includes the technology
-
protein design! We are a leading research group dedicated to implementing generative AI models to revolutionize protein engineering and design. Our multidisciplinary team combines expertise in
-
engineering and design. Our multidisciplinary team combines expertise in bioinformatics, machine learning, and experimental molecular biology to tackle pressing challenges in protein design. Whom would we like
-
structures Desirable but not required/ Nice to have Experience with NGS data Software debugging, profiling, versioning Experience with ModelX toolsuite Proven experience with FoldX protein engineering
-
also an important experimental component. We are past and current members of many large scale international functional genomics projects, such as ENCODE, GTEx, BluePrint and others. Whom would we like
-
small molecules. An advance in this field can thus unleash new approaches for the treatment of many diseases of current unmet need. Jointly funded by the European Research Council and UK Research and